Andean Precious Metals (CVE:APM) Shares Down 10.4% – Here’s What Happened

Andean Precious Metals Corp. (CVE:APM) shares were down 10.4% during trading on Tuesday . The stock traded as low as C$1.12 and last traded at C$1.12. Approximately 535,049 shares were traded during trading, an increase of 177% from the average daily volume of 193,465 shares. The stock had previously closed at C$1.25.

Analyst Ratings Changes

Separately, Desjardins upgraded Andean Precious Metals to a “moderate buy” rating in a research note on Thursday, October 31st.

Andean Precious Metals Stock Performance

The company’s 50 day moving average is C$1.46 and its 200 day moving average is C$1.25. The firm has a market cap of C$170.27 million, a P/E ratio of 3.00 and a beta of 1.22.

Insider Activity at Andean Precious Metals

In other Andean Precious Metals news, insider 2176423 Ontario Ltd. purchased 84,400 shares of the firm’s stock in a transaction on Tuesday, October 8th. The stock was purchased at an average cost of C$1.51 per share, for a total transaction of C$127,359.60. Insiders acquired a total of 306,200 shares of company stock worth $432,953 in the last quarter. 69.37% of the stock is owned by insiders.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.